Cargando…
Individualized prophylaxis for optimizing hemophilia care: can we apply this to both developed and developing nations?
Prophylaxis is considered optimal care for hemophilia patients to prevent bleeding and to preserve joint function thereby improving quality of life (QoL). The evidence for prophylaxis is irrefutable and is the standard of care in developed nations. Prophylaxis can be further individualized to improv...
Autores principales: | Poon, Man-Chiu, Lee, Adrienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056486/ https://www.ncbi.nlm.nih.gov/pubmed/27766058 http://dx.doi.org/10.1186/s12959-016-0096-y |
Ejemplares similares
-
Optimization of prophylaxis for hemophilia A
por: Herbert, Robert D., et al.
Publicado: (2018) -
Correction: Optimization of prophylaxis for hemophilia A
por: Herbert, Robert D., et al.
Publicado: (2018) -
Prophylaxis in older Canadian adults with hemophilia A: lessons and more questions
por: Jackson, Shannon C, et al.
Publicado: (2015) -
Management of surgery in persons with hemophilia A receiving emicizumab prophylaxis: data from a national hemophilia treatment center
por: Cohen, Omri, et al.
Publicado: (2023) -
Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low‐dose secondary prophylaxis study
por: Wu, Runhui, et al.
Publicado: (2021)